NCT07152821
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07152821
Title Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcinoma (BATTMAN)
Acronym BATTMAN
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Canadian Cancer Trials Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
BCCA - Prince George RECRUITING Prince George British Columbia V2M 7E9 Canada Details
BCCA - Vancouver RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
Kingston Health Sciences Centre RECRUITING Kingston Ontario K7L 2V7 Canada Details
Lakeridge Health Oshawa RECRUITING Oshawa Ontario L1G 2B9 Canada Details
Ottawa Hospital Research Institute RECRUITING Ottawa Ontario K1H 8L6 Canada Details
Niagara Health System RECRUITING St. Catharines Ontario L2S 0A9 Canada Details
North York General Hospital RECRUITING Toronto Ontario M2K 1E1 Canada Details
Sinai Health System RECRUITING Toronto Ontario M5G 1X5 Canada Details
University Health Network RECRUITING Toronto Ontario M5G 2M9 Canada Details
Centre Integre de Sante et de Services Sociaux RECRUITING Greenfield Park Quebec J4V 2H1 Canada Details
Allan Blair Cancer Centre RECRUITING Regina Saskatchewan S4T 7T1 Canada Details
Saskatoon Cancer Centre RECRUITING Saskatoon Saskatchewan S7N 4H4 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field